IPO Trending
NEPHROPLUSEQ / NSE, BSEListed

Nephrocare Health Services Limited

Incorporated in 2010, Nephrocare Health Services Ltd. provides comprehensive dialysis care through an extensive network of clinics across India and select international markets. As of March 31, 2025, the company operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal—including the world’s largest dialysis clinic in Uzbekistan. Nephrocare serves 269 cities across 21 states and 4 union territories, with nearly 77% of its centers located in tier II and III regions to improve access for underserved populations. In FY 2025, it treated 29,281 patients and delivered over 2.88 million dialysis sessions, representing about 10% of India’s dialysis patient base. The company managed 5,068 dialysis machines by March 2025, demonstrating consistent growth over prior years. Nephrocare has also partnered with leading hospital chains such as Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers and enhance service reach.

₹438 - ₹46014.08x sub
Listed Price491.70
Listing Gain+6.89%
TimelineBookbuilding IPO
Open10 Dec 2025
Close12 Dec 2025
Allotment15 Dec 2025
Listing17 Dec 2025

Quota Reservation Portions

AnchorPortion: 56,57,919 shares
29.88%
QIBPortion: 37,68,224 shares
19.9%
HNIPortion: 28,27,843 shares
14.93%
RetailPortion: 65,98,301 shares
34.85%
EmployeePortion: 83,532 shares
0.44%

Minimum Application Bracket Matrix

Retail1 lots / 32 shares
₹14,720
sHNI14 lots / 448 shares
₹2,06,080
bHNI68 lots / 2,176 shares
₹10,00,960

About the Company

Incorporated in 2010, Nephrocare Health Services Ltd. provides comprehensive dialysis care through an extensive network of clinics across India and select international markets. As of March 31, 2025, the company operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal—including the world’s largest dialysis clinic in Uzbekistan. Nephrocare serves 269 cities across 21 states and 4 union territories, with nearly 77% of its centers located in tier II and III regions to improve access for underserved populations. In FY 2025, it treated 29,281 patients and delivered over 2.88 million dialysis sessions, representing about 10% of India’s dialysis patient base. The company managed 5,068 dialysis machines by March 2025, demonstrating consistent growth over prior years. Nephrocare has also partnered with leading hospital chains such as Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers and enhance service reach.

Company Promoters

Vikram VuppalaBessemer Venture Partners TrustEdoras Investment Holdings Pte. Ltd.Healthcare Parent LimitedInvestcorp Private Equity Fund IIInvestcorp Growth Opportunity Fund